TDF v. ADV |
2.22 |
(0.99–4.94) |
0.05 |
HBV load at baseline |
- per log10 copies/mL HBV-DNA |
0.66 |
(0.55–0.80) |
<0.001 |
- < 2000 copies/mL |
1.00 |
** |
** |
- 2000 – 10,000 copies/mL |
0.12 |
(0.03–0.46) |
0.002 |
- > 10,000 copies/mL |
0.05 |
(0.02–0.14) |
<0.001 |
Presence of HBe antigen in serum |
0.13 |
(0.04–0.41) |
<0.001 |
Presence of YMDD mutation |
0.77 |
(0.29–2.07) |
0.6 |
Presence of Pre C mutation |
0.60 |
(0.28–1.28) |
0.2 |
HIV load at baseline (per log10 HIV-RNA) |
0.85 |
(0.47–1.54) |
0.6 |
Duration of HIV infection (per year) |
0.95 |
(0.88–1.02) |
0.14 |
CD4+ Cell Count (≥ 402/mm3) |
0.74 |
(0.42–1.31) |
0.3 |
METAVIR Fibrosis F0–F2 vs F3–F4 |
1.72 |
(0.78–3.79) |
0.2 |
ALT level at baseline (≥72 UI/mL = median) |
0.46 |
(0.25–0.85) |
0.01 |
Additional HCV co-infection |
1.42 |
(0.44–4.58) |
0.6 |
Alcohol consumption (cut at the median) |
0.71 |
(0.40–1.29) |
0.3 |